Published in Anal Biochem on November 01, 1969
Formation of molecular complexes between a structurally defined M protein and acylated or deacylated lipoteichoic acid of Streptococcus pyogenes. J Bacteriol (1982) 2.22
Acute haemodynamic and metabolic effects of felodipine in congestive heart failure. Br Heart J (1984) 1.39
Hypoketonaemic effect of L-alamine. Specific decrease in blood concentrations of 3-hydroxybutyrate in the rat. Biochem J (1977) 0.95
Effect of L-alanine infusion on gluconeogenesis and ketogenesis in the rat in vivo. Biochem J (1978) 0.87
Effect of heparin on serum binding of propranolol in the acute phase of myocardial infarction. Br J Clin Pharmacol (1981) 0.81
The effects of intravenous isoxsuprine on blood viscosity in patients with occlusive peripheral arterial disease. Br J Clin Pharmacol (1978) 0.76
Differences between acute and long-term metabolic and endocrine effects of oral beta-adrenoceptor agonist therapy with pirbuterol for cardiac failure. Br J Clin Pharmacol (1987) 0.76
The turnover of glycerol and free fatty acid in blood of genetically obese mice. Biochem J (1972) 0.75
Effect of timolol maleate on pacing induced myocardial ischaemia. Br Heart J (1984) 0.75
Plasma binding of thiopentone in late pregnancy. Br J Clin Pharmacol (1983) 0.75
Impairment of renal function with increasing blood lead concentrations in the general population. The Cadmibel Study Group. N Engl J Med (1992) 2.17
Exposure to lead by the oral and the pulmonary routes of children living in the vicinity of a primary lead smelter. Environ Res (1980) 2.07
Epidemiological survey of workers exposed to cadmium. Arch Environ Health (1974) 1.95
In vivo measurement of liver and kidney cadmium in workers exposed to this metal: its significance with respect to cadmium in blood and urine. Environ Res (1981) 1.81
Assessment of the permissible exposure level to manganese in workers exposed to manganese dioxide dust. Br J Ind Med (1992) 1.54
Continuous-flow system for automation of latex immunoassay by particle counting. Clin Chem (1983) 1.52
Renal function and historical environmental cadmium pollution from zinc smelters. Lancet (1994) 1.45
Dose-response relations between urinary cadmium and tubular proteinuria in adult workers . Am J Ind Med (1997) 1.41
Health significance of cadmium induced renal dysfunction: a five year follow up. Br J Ind Med (1989) 1.39
Assessment of urinary retinol-binding protein as an index of proximal tubular injury. Clin Chem (1987) 1.36
Measurement of urinary hippuric and m-methylhippuric acids by gas chromatography. Br J Ind Med (1973) 1.25
Investigations on the lung and kidney function in workers exposed to cadmium. Environ Health Perspect (1979) 1.24
Markers of early renal changes induced by industrial pollutants. I. Application to workers exposed to mercury vapour. Br J Ind Med (1993) 1.18
Characterization of the proteinuria in cadmium-exposed workers. Int Arch Occup Environ Health (1976) 1.18
Proteinuria: changes and mechanisms in toxic nephropathies. Crit Rev Toxicol (1991) 1.17
Environmental exposure to cadmium and renal function of aged women in three areas of Belgium. Environ Res (1981) 1.17
Early detection of the nephrotoxic effects of industrial chemicals: state of the art and future prospects. Am J Ind Med (1987) 1.17
Markers of early renal changes induced by industrial pollutants. III. Application to workers exposed to cadmium. Br J Ind Med (1993) 1.16
Serum Clara cell protein: an indicator of bronchial cell dysfunction caused by tobacco smoking. Environ Res (1994) 1.12
Markers of early renal changes induced by industrial pollutants. II. Application to workers exposed to lead. Br J Ind Med (1993) 1.10
Carcinogenicity, teratogenicity and mutagenicity of arsenic. Mutat Res (1980) 1.08
Carcinogenicity and mutagenicity of chromium. Mutat Res (1980) 1.07
Reversibility of microproteinuria in cadmium workers with incipient tubular dysfunction after reduction of exposure. Am J Ind Med (1997) 1.03
Public health implications of environmental exposure to cadmium and lead: an overview of epidemiological studies in Belgium. Working Groups. J Cardiovasc Risk (1996) 1.03
Characterization of cadmium proteinuria in man and rat. Environ Health Perspect (1984) 1.02
Transfer of cadmium from a sandy acidic soil to man: a population study. Environ Res (1992) 1.01
Influence of 2,3-dimercaptopropane-1-sulfonate and dimercaptosuccinic acid on the mobilization of mercury from tissues of rats pretreated with mercuric chloride, phenylmercury acetate or mercury vapors. Toxicology (1989) 1.00
Decrease of erythrocyte and glomerular membrane negative charges in chronic cadmium poisoning. Br J Ind Med (1988) 0.98
Urinary excretion of mercury after occupational exposure to mercury vapour and influence of the chelating agent meso-2,3-dimercaptosuccinic acid (DMSA). Br J Ind Med (1991) 0.98
Hypertension caused by low-level lead exposure: myth or fact? J Cardiovasc Risk (1994) 0.97
Response of free erythrocyte porphyrin and urinary delta-aminolevulinic acid in men and women moderately exposed to lead. Int Arch Arbeitsmed (1975) 0.97
Nephropathies and exposure to perchloroethylene in dry-cleaners. Lancet (1992) 0.96
Effects of exposure to cadmium on calcium metabolism: a population study. Br J Ind Med (1991) 0.96
Cadmium and the kidney. Br J Ind Med (1986) 0.95
Comparative study of effect of inorganic lead and cadmium on blood delta-aminolevulinate dehydratase in man. Br J Ind Med (1973) 0.93
Impact of environmental cadmium pollution on cadmium exposure and body burden. Arch Environ Health (1992) 0.93
Urine protein 1: a sex-dependent marker of tubular or glomerular dysfunction. Clin Chem (1989) 0.92
The relationship between cadmium exposure or body burden and the concentration of cadmium in blood and urine in man. Int Arch Occup Environ Health (1976) 0.91
Hematopoietic and lymphatic malignancies in vehicle mechanics. Crit Rev Toxicol (1997) 0.91
Assessment of the filtration reserve capacity of the kidney in workers exposed to cadmium. Br J Ind Med (1991) 0.91
Long-term toxicity of intravenous mercury injection. Lancet (1996) 0.90
Retinol binding protein in urine: a more practical index than urinary beta 2-microglobulin for the routine screening of renal tubular function. Clin Chem (1981) 0.89
Disturbance of sialic acid metabolism by chronic cadmium exposure and its relation to proteinuria. Toxicol Appl Pharmacol (1991) 0.89
The effects of low doses of cadmium-metallothionein on the renal uptake of beta 2-microglobulin in rats. Toxicol Appl Pharmacol (1987) 0.89
Determination of beta 2-microglobulin in human urine and serum by latex immunoassay. Clin Chem (1981) 0.88
Urinary kallikrein activity in workers exposed to cadmium, lead, or mercury vapour. Br J Ind Med (1990) 0.88
Urinary protein 1 or Clara cell protein: a new sensitive marker of proximal tubular dysfunction. Kidney Int Suppl (1994) 0.88
Mutagenicity and teratogenicity of mercury compounds. Mutat Res (1983) 0.86
Low-level lead exposure and blood pressure. J Hum Hypertens (1995) 0.85
Occupational exposure to mercury vapors and biological action. Arch Environ Health (1973) 0.85
The assessment of biomarkers to detect nephrotoxicity using an integrated database. Environ Res (1997) 0.85
Investigations of factors influencing exposure and response to lead, mercury, and cadmium in man and in animals. Environ Health Perspect (1978) 0.84
Intestinal-type alkaline phosphatase in urine as an indicator of mercury induced effects on the S3 segment of the proximal tubule. Nephrol Dial Transplant (1992) 0.84
Adducts to macromolecules in the biological monitoring of workers exposed to polycyclic aromatic hydrocarbons. Crit Rev Toxicol (1993) 0.84
Microtransferrinuria is a more sensitive indicator of early glomerular damage in diabetes than microalbuminuria. Clin Chem (1988) 0.83
Pronounced decrease of Tamm-Horsfall proteinuria in diabetics. Clin Chem (1987) 0.83
Biological surveillance of workers exposed to dimethylformamide and the influence of skin protection on its percutaneous absorption. Int Arch Occup Environ Health (1980) 0.83
Long-term pulmonary and systemic toxicity following intravenous mercury injection. Arch Toxicol (1997) 0.83
Dimethylformamide (DMF) hepatotoxicity. Toxicology (1987) 0.82
Latex immunoassay of retinol-binding protein. Clin Chem (1982) 0.82
Comparison, by sodium dodecyl sulfate-polyacrylamide gel electrophoresis, of urinary proteins excreted by workers exposed to cadmium, mercury or lead. Toxicol Lett (1980) 0.82
Arsenic uptake, cytotoxicity and detoxification studied in mammalian cells in culture. Arch Toxicol (1985) 0.81
Proximal tubular injury in Chinese herbs nephropathy: monitoring by neutral endopeptidase enzymuria. Kidney Int (1997) 0.80
Inhibition of human erythrocyte delta-aminolevulinate dehydratase by lead. In vitro artifact or real phenomenon in vivo? Int Arch Arbeitsmed (1974) 0.80
Potentiation of cadmium nephrotoxicity by acetaminophen. Arch Toxicol (1988) 0.78
Is a positive association between lead exposure and blood pressure supported by animal experiments? Curr Opin Nephrol Hypertens (1994) 0.78
Isolation of a new low molecular weight beta 2-globulin from urine of a worker with chronic cadmium poisoning. Biochem Biophys Res Commun (1980) 0.78
The influence of sex and of chelation therapy on erythrocyte protoporphyrin and urinary delta-aminolevulinic acid in lead-exposed workers. J Occup Med (1979) 0.78
Urinary excretion of lead and mercury after oral administration of meso-2,3-dimercaptosuccinic acid in patients with motor neurone disease. Int Arch Occup Environ Health (1995) 0.78
Comparative anticholinesterase action of organophosphorus insecticides in vertebrates. Toxicol Appl Pharmacol (1968) 0.78
The effects of sodium chromate and carbon tetrachloride on the urinary excretion and tissue distribution of cadmium in cadmium-pretreated rats. Toxicol Appl Pharmacol (1981) 0.78
Urinary excretion of proteins and enzymes in workers exposed to hydrocarbons in a shoe factory. Int Arch Occup Environ Health (1991) 0.77
Development and calibration of an in vivo bone lead measurement system, and its application to an industrially exposed population. Basic Life Sci (1993) 0.77
Comparison of in vivo effect of inorganic lead and cadmium on glutathione reductase system and delta-aminolevulinate dehydratase in human erythrocytes. Br J Ind Med (1975) 0.77
Comparison of assay methods for studying O,O-diethyl, O-p-nitrophenyl phosphate (paraoxon) detoxication in vitro. Biochem Pharmacol (1969) 0.76
Interaction between paraoxon and tri-o-tolyl phosphate in rats. Toxicol Appl Pharmacol (1969) 0.76
The influence of two barrier creams on the percutaneous absorption of m-xylene in man. J Occup Med (1978) 0.76
Short report: low-level lead exposure does not increase the blood pressure in the general population. Cadmibel Study Group. J Hypertens (1993) 0.76
Epidemiological survey of workers exposed to inorganic germanium compounds. Occup Environ Med (2000) 0.75
Significance of hyperferritinuria. Clin Chem (1983) 0.75
Gentamicin nephrotoxicity in cadmium, lead and mercury pretreated rats. Toxicology (1983) 0.75
[Occupational health in Belgium]. Soz Praventivmed (1978) 0.75
Lung retention and bioavailability of arsenic after single intratracheal administration of sodium arsenite, sodium arsenate, fly ash and copper smelter dust in the hamster. Environ Geochem Health (1995) 0.75
Evaluation of the subacute nephrotoxicity of cyclohexane and other industrial solvents in the female Sprague-Dawley rat. Toxicol Lett (1989) 0.75
The determination of trace levels of arsenic in human biological materials. Arch Toxicol (1979) 0.75
Comparison of turbidimetry with particle counting for the determination of human beta 2-microglobulin by latex immunoassay (LIA). Clin Chim Acta (1982) 0.75
Cellular metabolism of arsenic studied in mammalian cellsin vitro. Environ Geochem Health (1989) 0.75
Effect of oral protein load on urinary protein excretion in workers exposed to cadmium and to lead. Am J Ind Med (1996) 0.75
Comparison of three techniques for carboxyhaemoglobin determination. Int Arch Arbeitsmed (1974) 0.75
Relationship between cancer and occupational exposure to chemicals: an overview of the evidence. Recent Results Cancer Res (1991) 0.75
[Evaluation of the exposure of different groups of the Belgian population (fetus, children, adult men and women) to heavy metals]. Arch Belg Med Soc (1981) 0.75
Characterization of a diglyceride lipase in rat heart and intestine. Life Sci II (1971) 0.75
Detection of anti-laminin antibodies in sera by latex agglutination. Clin Chem (1986) 0.75